Medication info
Glogrel Tablets 75 mg (Clopidogrel Sulfate)

Glogrel Tablets 75 mg (Clopidogrel Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Korea Nelson Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201309184 · Approved 2013.09.03 · Insurance code 656701900

Summary

Main use
Improvement of symptoms of atherosclerosis and acute coronary syndrome; reduction of thromboembolic risk in atrial fibrillation
Who takes it
Adults
Adult dose
1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), on the day treatment with this medicine is initiated, start with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. In this case, aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. In this case, aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease with a bleeding diathesis is limited. This medicine may be administered regardless of food intake.

Ingredients

Manufacturer
Korea Nelson Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of atherosclerosis and acute coronary syndrome; reduction of thromboembolic risk in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral artery disease
  • acute coronary syndrome
  • unstable angina
  • non-Q wave myocardial infarction
  • cardiovascular abnormalities
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atrial fibrillation
  • atherothrombosis
View approved original text

This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral artery disease. It also improves atherosclerotic symptoms that may lead to cardiovascular mortality, myocardial infarction, and stroke in patients with acute coronary syndrome who have undergone or are to undergo drug therapy, coronary intervention, or coronary artery bypass surgery. It helps reduce the risk of thromboembolism and stroke in adult patients with atrial fibrillation who have vascular risk factors but are not suitable for vitamin K antagonist therapy and have a low risk of bleeding. This medication is used to effectively improve and prevent various vascular-related diseases and risks.

How to take

Adult dose

1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), on the day treatment with this medicine is initiated, start with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. In this case, aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. In this case, aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease with a bleeding diathesis is limited. This medicine may be administered regardless of food intake.

Precautions

This medication helps prevent blood platelets from aggregating, which helps prevent thrombosis. Its efficacy may be reduced in individuals genetically deficient in certain enzymes, and alternative treatment methods should be considered in such cases. Also, concomitant use with medications that activate certain enzymes may increase the risk of bleeding, so such combinations should be avoided. This medication should not be administered to patients with allergies to this drug, those with bleeding, severely damaged liver function, nursing mothers, and patients with lactose intolerance. If bleeding symptoms occur during treatment, contact a physician immediately. Patients, particularly those at risk for gastrointestinal or ocular bleeding, should use caution. Patients scheduled for surgery should discontinue this medication 5-7 days before the procedure and use caution when taking it with other medications that pose a risk of bleeding. Since this medication may increase the risk of bleeding, regular monitoring of status through blood tests is recommended. During the course of this medication, bleeding may take longer to stop than usual, so caution is required in case of injuries. The concomitant use of this medication with aspirin or other antiplatelet or anticoagulant agents may increase the risk of bleeding, so it should be discussed with a physician. During pregnancy, the risk to the fetus is not significant; however, the risk of bleeding increases during delivery, so it is advisable to discontinue its use prior to labor. If nursing, this medication may pass into breast milk, so whether to continue breastfeeding should be discussed with a physician. Children, the elderly, and patients with impaired kidney or liver function should be monitored more closely when taking this medication. Overdose may increase the risk of bleeding, and since there is no specific antidote, consult medical personnel immediately. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

  • bleeding
  • gastrointestinal bleeding
  • bleeding requiring hospitalization
  • purpura
  • contusion
  • hematoma
  • epistaxis
  • hematoma
  • hematuria
  • ocular hemorrhage
Show 88 more
  • intracranial bleeding
  • significant bleeding
  • life-threatening bleeding
  • fatal bleeding
  • hemorrhagic stroke
  • blood transfusion requirement
  • thrombocytopenia
  • neutropenia
  • aplastic anemia
  • gastrointestinal symptoms
  • abdominal pain
  • dyspepsia
  • diarrhea
  • nausea
  • rash
  • pruritus
  • depression
  • upper respiratory tract infection
  • shortness of breath
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • headache
  • dizziness
  • chest pain
  • traumatic injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • arthralgia
  • low back pain
  • depression
  • insomnia
  • anxiety
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • gastritis
  • stomatitis
  • hepatitis
  • acute liver failure
  • maculopapular rash
  • erythematous skin rash
  • urticaria
  • angioedema
  • vesicular dermatitis
  • drug-induced hypersensitivity syndrome
  • eosinophilia
  • drug rash
  • eczema
  • lichen planus
  • arthritis
  • myalgia
  • glomerulonephritis
  • gynecomastia
  • fever
  • abnormal liver function tests
  • elevated blood creatinine
  • allergy symptoms
  • ischemic necrosis
  • hemorrhagic arthropathy
  • hematuria
  • hemoptysis
  • retroperitoneal hemorrhage
  • surgical wound bleeding
  • pulmonary hemorrhage
  • purpura
  • leukemia
  • leukopenia
  • eosinophilia
  • menorrhagia
  • hemothorax
  • herpes zoster
  • erythematous rash
  • maculopapular rash
  • urticaria
  • renal dysfunction
  • acute kidney injury
  • cholecystitis
  • hematemesis
  • spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is best to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage helps maintain the medication's efficacy over time.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.